Fenofibrate is also known by its brand names, most notably Tricor [1]. It is also marketed under the brand names Fenoglide and Lipofen [2].
What is Fenofibrate used for?
Fenofibrate is a medication primarily used to treat high cholesterol and triglyceride levels in the blood [1][3]. It is prescribed to reduce the risk of cardiovascular events such as heart attack and stroke, particularly in patients with high cholesterol and existing cardiovascular disease [3].
How does Fenofibrate work?
As a fibrate drug, fenofibrate works by decreasing the production of cholesterol and triglycerides in the liver and increasing the removal of these fats from the blood [4]. It primarily targets very-low-density lipoprotein (VLDL) particles, which are a major carrier of triglycerides [4].
When can generic versions of Fenofibrate become available?
The availability of generic versions of fenofibrate depends on patent expirations and any associated regulatory exclusivity periods [5]. For instance, certain patents related to fenofibrate formulations have expired, allowing for the introduction of generic options [6]. Information on specific patent expiries can be found on platforms like DrugPatentWatch.com [5].
Are there other drugs similar to Fenofibrate?
Other fibrate medications are available and work on similar principles to fenofibrate, including gemfibrozil and bezafibrate [4]. These drugs are also used to manage dyslipidemia, or abnormal levels of lipids in the blood [4].
What are the potential side effects of Fenofibrate?
Common side effects of fenofibrate can include digestive issues like nausea, abdominal pain, and diarrhea. Some individuals may experience headaches, back pain, or muscle aches [7]. More serious, though less common, side effects can involve liver problems, pancreatitis, and rhabdomyolysis (muscle breakdown) [7].
What is the difference between Fenofibrate and statins?
Fenofibrate and statins are both used to manage cholesterol but belong to different drug classes and work through distinct mechanisms [3][4]. Statins, such as atorvastatin or simvastatin, primarily target lowering LDL (low-density lipoprotein) cholesterol, often referred to as "bad" cholesterol, by reducing its production in the liver [3]. Fenofibrate, on the other hand, is more effective at lowering triglycerides and increasing HDL (high-density lipoprotein) cholesterol, or "good" cholesterol," although it also has some effect on LDL [3][4]. They are sometimes prescribed together for patients with mixed dyslipidemia who do not achieve their goals with a single medication [3].